Get the Stockscreener App
63.55
0.08%
0.05
After Hours:
63.55
Biomarin Pharmaceutical Inc Stock (BMRN) Latest News
Stoneridge Investment Partners LLC Acquires 6,355 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Advisors Preferred LLC Acquires Shares of 14,329 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Brokerages Set BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Target Price at $94.20 - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Holdings Decreased by Janney Montgomery Scott LLC - MarketBeat
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - AccessWire
EULAV Asset Management Has $7.10 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Lecap Asset Management Ltd. Sells 5,863 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Discover Why BioMarin Pharmaceutical Could Skyrocket in Value! - Reporteros del Sur
Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts - Insider Monkey
Insiders At BioMarin Pharmaceutical Sold US$3.6m In Stock, Alluding To Potential Weakness - Simply Wall St
abrdn plc Acquires 168,121 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Robeco Institutional Asset Management B.V. Sells 124,092 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Mediolanum International Funds Ltd Invests $1.24 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Level Wealth Management LLC Acquires New Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
3 Reasons Growth Investors Will Love BioMarin (BMRN) - Yahoo Finance Australia
BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET - Marketscreener.com
BioMarin Earnings Call: CEO Alexander Hardy to Present Strategic Vision & 2024 Results - StockTitan
Prediction: This Pharma Stock Will Be the Best Performer in 2025 - 24/7 Wall St.
Zacks.com featured highlights BioMarin, Cheesecake Factory, Leidos and The Ensign - Yahoo Finance
Swedbank AB Has $28.40 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BofA Adjusts Price Target on BioMarin Pharmaceutical to $99 From $100 -February 03, 2025 at 10:27 am EST - Marketscreener.com
Top 10 Takeover Targets of 2025 - Genetic Engineering & Biotechnology News
Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now? - Insider Monkey
BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now? - Yahoo Finance
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock - Yahoo Finance
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Atomi Financial Group Inc. - Defense World
12 Best Depressed Stocks to Invest in Now - Insider Monkey
Merit Financial Group LLC Invests $317,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
BioMarin Pharmaceuticals: Share Downdraft Combined With VOXZOGO Potential Makes A Buy - Seeking Alpha
BioMarin turns to ex-Roche dealmaker James Sabry to build ‘next version’ of 27-year-old company - Endpoints News
Why Is Andreas Halvorsen Bullish On BioMarin Pharmaceutical Inc. (BMRN) Now? - Yahoo Finance
Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign - Yahoo Finance
Brokers Offer Predictions for BMRN FY2025 Earnings - Defense World
Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks - Insider Monkey
Cantor Fitzgerald Predicts BMRN FY2025 Earnings - MarketBeat
Fort Washington Investment Advisors Inc. OH Sells 12,170 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Sabry Lays Out BioMarin’s New Business Development Plan - News & Insights
Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects - Yahoo Finance
BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025 - Insider Monkey
Here is Why Growth Investors Should Buy BioMarin (BMRN) Now - Yahoo Finance
10 Under-the-Radar Stocks with Massive Upside for 2025 - Insider Monkey
Avanza Fonder AB Takes Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
Head to Head Comparison: BioMarin Pharmaceutical (NASDAQ:BMRN) and Acura Pharmaceuticals (OTCMKTS:ACUR) - Defense World
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Sees Large Decrease in Short Interest - MarketBeat
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? - Benzinga
BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Down 3%Should You Sell? - MarketBeat
BioMarin Pharmaceutical Target of Unusually High Options Trading (NASDAQ:BMRN) - MarketBeat
BioMarin Pharmaceutical Sees Unusually Large Options Volume (NASDAQ:BMRN) - Defense World
BioMarin stock touches 52-week low at $60.77 amid challenges - MSN
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):